AHG — Stock Film
STOCK FILMSCENE 1/11AHG · $1.02
Stock Expert AI presents
AHG
Akso Health Group
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Akso Health Group. A quick introduction.

On the stock market since 2017, it operates in the world of money and finance. It has 9 employees. Now — the numbers.

on the stock market since 2017
9 employees
$236.8M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $2.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are growing overall, with a pause along the way.

Average growth of 23% a year over the last 4 years. Red columns mark years that ended in a loss.

$6M
2022
$13.2M
2023
$2.4M
2024
$14.8M
2025
$13.8M
2026
In the vault right now:
$0
DEBT: $376K
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

Every quarter, analysts set a profit bar.
How many of the last 4 did the company clear?
2 / 4
EXPECTATIONS MET OR BEATEN
2
Jul 2024
Oct 2024
Mar 2025
Apr 2025
2 TIMES IN THE LAST 4 QUARTERS
A mixed scorecard.
THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 95% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
The product is selling

Sales run at $13.8M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $18.7M against $13.8M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

3
THE RISKS · 3/3
Executives lean toward selling

Over the last 12 months, executives reported 11 sells against just 1 buy. Not an alarm bell by itself, but a number worth watching.

FINALE · THE GRADE
B
0 / 100 · MoonshotScore

On our five-subject report card, AHG sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: AHG is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film